Although more than ten other risk loci, including genes like STX or MOBP (for a complete list, see Table 5 in Wen et al. [49]), have been identified for PSP, the importance of MAPT mutations remains central, with 15 such mutations identified in PSP patients. This evidence concerns the gene MOBP and supranuclear palsy, progressive, 1.